ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER

Clinical trials for ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER trials appear

Sign up with your email to follow new studies for ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy tested for hard-to-treat colorectal cancer

Disease control Completed

This early-phase trial tested a combination of two drugs (MEK162 and mFOLFIRI) in 25 adults with advanced RAS-positive colorectal cancer that had stopped responding to standard treatment. The main goal was to find the safest dose and check for side effects. Researchers also looke…

Matched conditions: ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER

Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control

Last updated Jun 11, 2026 12:11 UTC

ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER

Get alerted when new ADVANCED KRAS POSITIVE METASTATIC COLORECTAL CANCER trials appear

New combo therapy tested for hard-to-treat colorectal cancer